Open AccessAre off-target effects of imatinib the key to improving beta-cell function in diabetes?
Author(s) -
Nils Welsh
Publication year - 2022
Publication title -
upsala journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.808
H-Index - 41
eISSN - 2000-1967
pISSN - 0300-9734
DOI - 10.48101/ujms.v127.8841
Subject(s) - imatinib , medicine , imatinib mesylate , tyrosine kinase inhibitor , tyrosine kinase , function (biology) , diabetes mellitus , beta (programming language) , cell , cancer research , disease , pharmacology , bioinformatics , microbiology and biotechnology , endocrinology , receptor , biology , biochemistry , cancer , computer science , programming language , myeloid leukemia